Splenectomy; Status
13
7
7
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method
Evaluation of the Effectiveness of an Educational Intervention in Splenectomized Patients
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients
The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis Patients
Meningococcal B Vaccine in Patients with Asplenia
Total Splenectomy vs Partial Splenectomy in Non-malignant Hemoglobinopathies : Study Comparing the Effectiveness
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
A Nationwide Italian Survey on Asplenia
Zinc Supplementation on Cellular Immunity in Thalassemia Major